NRX Pharmaceuticals, Inc. current report, 21 April 2021

Vollständiges Dokument

Business Context and Reporting Period

This Form 8-K is filed by Big Rock Partners Acquisition Corp. (not NRX Pharmaceuticals, Inc.) on April 21, 2021. The registrant is a Special Purpose Acquisition Company (SPAC) listed on the NASDAQ under the symbols BRPAU, BRPA, BRPAR, and BRPAW. The report details the results of a special meeting of stockholders held on the filing date.

Key Financial Metrics

The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or debt levels, as this is a current report regarding a corporate governance event rather than a periodic financial statement.

  • Share Conversion: Stockholders holding an aggregate of 330 public shares exercised their right to convert shares into cash in connection with the extension of the business combination deadline.
  • Warrant Exercise Price: $11.50 per share.

Material Changes

The primary material change reported is the approval of an amendment to the Company's amended and restated certificate of incorporation. This amendment extends the deadline for the Company to consummate an initial business combination to May 24, 2021.

Voting Results:

  • For: 1,729,484
  • Against: 1,434
  • Abstain: 0
  • Broker Non-Votes: 0

Outlook, Risks, and Management Commentary

Following the stockholder vote, the Company filed the amendment with the Secretary of State of Delaware. The Company now has until May 24, 2021, to complete a business combination. The filing does not contain specific management commentary on future risks, contingencies, or unusual items beyond the procedural details of the extension and the redemption of 330 shares.

Investor Verification Checklist

  • Verify the new deadline for the initial business combination is May 24, 2021.
  • Confirm the number of shares redeemed (330) and the impact on the trust account balance (not explicitly stated in this text).
  • Review the attached Exhibit 3.1 for the full text of the amendment to the Certificate of Incorporation.
  • Note that the registrant is Big Rock Partners Acquisition Corp., not NRX Pharmaceuticals, Inc.